Biggest, richest, strongest, frothiest, riskiest; no matter what superlatives you want to apply, the biotech initial public offering (IPO) boom of 2018 was record breaking. In early December, Moderna Therapeutics’ US$604 million IPO — the largest ever for a venture-backed US biotech company — propelled the total capital raised in biotech IPOs during the year past the $8 billion threshold for the first time in the history of the sector…

Para acessar a publicação na íntegra clique aqui

Fonte: NATURE REVIEWS | DRUG DISCOVERY VOLUME 18 | JANUARY 2019 | 3